Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Finds New Obesity Drug Target

NEW YORK, June 10-Lexicon Genetics said today that it had identified and validated in vivo a new target for obesity treatments.


Researchers at Lexicon created a knockout mouse that was lacking a previously uncharacterized G-protein coupled receptor gene, LG747. These mice accumulated twice as much body fat as normal rodents, leading to an average 35 percent weight increase.


Lexicon plans to develop drugs that activate this receptor, in the hopes of finding treatments that reduce body fat and treat obesity-related disease.


For further information, see the company press release.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.